BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 24332384)

  • 1. Improvement in quality of life with left prefrontal transcranial magnetic stimulation in patients with pharmacoresistant major depression: acute and six month outcomes.
    Solvason HB; Husain M; Fitzgerald PB; Rosenquist P; McCall WV; Kimball J; Gilmer W; Demitrack MA; Lisanby SH
    Brain Stimul; 2014; 7(2):219-25. PubMed ID: 24332384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study.
    Janicak PG; Nahas Z; Lisanby SH; Solvason HB; Sampson SM; McDonald WM; Marangell LB; Rosenquist P; McCall WV; Kimball J; O'Reardon JP; Loo C; Husain MH; Krystal A; Gilmer W; Dowd SM; Demitrack MA; Schatzberg AF
    Brain Stimul; 2010 Oct; 3(4):187-99. PubMed ID: 20965447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period.
    Dunner DL; Aaronson ST; Sackeim HA; Janicak PG; Carpenter LL; Boyadjis T; Brock DG; Bonneh-Barkay D; Cook IA; Lanocha K; Solvason HB; Demitrack MA
    J Clin Psychiatry; 2014 Dec; 75(12):1394-401. PubMed ID: 25271871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression.
    Mantovani A; Pavlicova M; Avery D; Nahas Z; McDonald WM; Wajdik CD; Holtzheimer PE; George MS; Sackeim HA; Lisanby SH
    Depress Anxiety; 2012 Oct; 29(10):883-90. PubMed ID: 22689290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study.
    Philip NS; Dunner DL; Dowd SM; Aaronson ST; Brock DG; Carpenter LL; Demitrack MA; Hovav S; Janicak PG; George MS
    Brain Stimul; 2016; 9(2):251-7. PubMed ID: 26708778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice.
    Janicak PG; Dunner DL; Aaronson ST; Carpenter LL; Boyadjis TA; Brock DG; Cook IA; Lanocha K; Solvason HB; Bonneh-Barkay D; Demitrack MA
    CNS Spectr; 2013 Dec; 18(6):322-32. PubMed ID: 23895940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EEG synchronized left prefrontal transcranial magnetic stimulation (TMS) for treatment resistant depression is feasible and produces an entrainment dependent clinical response: A randomized controlled double blind clinical trial.
    George MS; Huffman S; Doose J; Sun X; Dancy M; Faller J; Li X; Yuan H; Goldman RI; Sajda P; Brown TR
    Brain Stimul; 2023; 16(6):1753-1763. PubMed ID: 38043646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial.
    Avery DH; Isenberg KE; Sampson SM; Janicak PG; Lisanby SH; Maixner DF; Loo C; Thase ME; Demitrack MA; George MS
    J Clin Psychiatry; 2008 Mar; 69(3):441-51. PubMed ID: 18294022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial.
    McGirr A; Van den Eynde F; Tovar-Perdomo S; Fleck MP; Berlim MT
    J Affect Disord; 2015 Mar; 173():216-20. PubMed ID: 25462419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depression (TRMD) Veteran patients: study protocol for a randomized controlled trial.
    Mi Z; Biswas K; Fairchild JK; Davis-Karim A; Phibbs CS; Forman SD; Thase M; Georgette G; Beale T; Pittman D; McNerney MW; Rosen A; Huang GD; George M; Noda A; Yesavage JA
    Trials; 2017 Sep; 18(1):409. PubMed ID: 28865495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Durability of the antidepressant effect of the high-frequency repetitive transcranial magnetic stimulation (rTMS) In the absence of maintenance treatment in major depression: a systematic review and meta-analysis of 16 double-blind, randomized, sham-controlled trials.
    Kedzior KK; Reitz SK; Azorina V; Loo C
    Depress Anxiety; 2015 Mar; 32(3):193-203. PubMed ID: 25683231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression.
    Berlim MT; Van den Eynde F; Tovar-Perdomo S; Chachamovich E; Zangen A; Turecki G
    World J Biol Psychiatry; 2014 Sep; 15(7):570-8. PubMed ID: 25050453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression.
    Avery DH; Holtzheimer PE; Fawaz W; Russo J; Neumaier J; Dunner DL; Haynor DR; Claypoole KH; Wajdik C; Roy-Byrne P
    Biol Psychiatry; 2006 Jan; 59(2):187-94. PubMed ID: 16139808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Vagus Nerve Stimulation Significantly Improves Quality of Life in Treatment-Resistant Major Depression.
    Conway CR; Kumar A; Xiong W; Bunker M; Aaronson ST; Rush AJ
    J Clin Psychiatry; 2018 Aug; 79(5):. PubMed ID: 30152645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: A fast road to remission?
    Duprat R; Desmyter S; Rudi de R; van Heeringen K; Van den Abbeele D; Tandt H; Bakic J; Pourtois G; Dedoncker J; Vervaet M; Van Autreve S; Lemmens GM; Baeken C
    J Affect Disord; 2016 Aug; 200():6-14. PubMed ID: 27107779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial.
    Lisanby SH; Husain MM; Rosenquist PB; Maixner D; Gutierrez R; Krystal A; Gilmer W; Marangell LB; Aaronson S; Daskalakis ZJ; Canterbury R; Richelson E; Sackeim HA; George MS
    Neuropsychopharmacology; 2009 Jan; 34(2):522-34. PubMed ID: 18704101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice.
    Carpenter LL; Janicak PG; Aaronson ST; Boyadjis T; Brock DG; Cook IA; Dunner DL; Lanocha K; Solvason HB; Demitrack MA
    Depress Anxiety; 2012 Jul; 29(7):587-96. PubMed ID: 22689344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.